Head-to-head · Cost-Efficiency Index
Roboclinic vs eMed
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Roboclinic
Cost-first shoppers who want likely a miscategorization -- not a genuine dedicated GLP-1 weight-loss storefront.
Visit RobocliniceMed
Cost-first shoppers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
Visit eMedThe verdict
Roboclinic takes it, leading the Cost-Efficiency Index 45 to 44. RoboClinic is not a dedicated GLP-1 weight-loss brand. eMed still earns a C — Cost-first shoppers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Roboclinic.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Roboclinic | eMed |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 44/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #467 | #472 |
Roboclinic
45/100Where the value is
- AI-assisted intake could speed up the initial assessment step
- Ultimately backed by OpenLoop Health, a real national telehealth clinical network
- Positions itself as covering broader health assessments, not just weight loss
The tradeoffs
- The roboclinic.com domain is dead/repurposed, redirecting to an unrelated business directory
- No dedicated GLP-1/weight-loss pricing, plans, or medication menu found
eMed
44/100Where the value is
- Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
- At-home blood collection makes lab work convenient
- Clinician review and ongoing side-effect plus adherence support
The tradeoffs
- Distributed mainly via employers, with limited direct cash-pay access
- No public transparent monthly price for individuals
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.